GO:0006996 | organelle organization | 31.94% (23/72) | 2.03 | 0.0 | 6e-06 |
GO:0030866 | cortical actin cytoskeleton organization | 6.94% (5/72) | 5.85 | 0.0 | 1.4e-05 |
GO:0071840 | cellular component organization or biogenesis | 45.83% (33/72) | 1.4 | 0.0 | 1.5e-05 |
GO:0016043 | cellular component organization | 44.44% (32/72) | 1.44 | 0.0 | 1.9e-05 |
GO:0051171 | regulation of nitrogen compound metabolic process | 40.28% (29/72) | 1.47 | 0.0 | 3.7e-05 |
GO:0032991 | protein-containing complex | 36.11% (26/72) | 1.55 | 0.0 | 6.8e-05 |
GO:0031267 | small GTPase binding | 8.33% (6/72) | 4.47 | 0.0 | 9.5e-05 |
GO:0030036 | actin cytoskeleton organization | 8.33% (6/72) | 4.29 | 1e-06 | 0.000169 |
GO:0048869 | cellular developmental process | 26.39% (19/72) | 1.82 | 1e-06 | 0.000208 |
GO:0051020 | GTPase binding | 8.33% (6/72) | 4.16 | 1e-06 | 0.000211 |
GO:0030435 | sporulation resulting in formation of a cellular spore | 6.94% (5/72) | 4.79 | 1e-06 | 0.000223 |
GO:0080090 | regulation of primary metabolic process | 38.89% (28/72) | 1.32 | 1e-06 | 0.000231 |
GO:1902533 | positive regulation of intracellular signal transduction | 11.11% (8/72) | 3.31 | 1e-06 | 0.000234 |
GO:0000915 | actomyosin contractile ring assembly | 4.17% (3/72) | 6.97 | 2e-06 | 0.000247 |
GO:0060255 | regulation of macromolecule metabolic process | 38.89% (28/72) | 1.3 | 2e-06 | 0.000264 |
GO:0044837 | actomyosin contractile ring organization | 4.17% (3/72) | 6.86 | 2e-06 | 0.000274 |
GO:1902531 | regulation of intracellular signal transduction | 15.28% (11/72) | 2.56 | 2e-06 | 0.000296 |
GO:0010556 | regulation of macromolecule biosynthetic process | 30.56% (22/72) | 1.52 | 3e-06 | 0.000317 |
GO:0008841 | dihydrofolate synthase activity | 2.78% (2/72) | 9.08 | 3e-06 | 0.000325 |
GO:0030029 | actin filament-based process | 8.33% (6/72) | 3.86 | 4e-06 | 0.000335 |
GO:0030120 | vesicle coat | 5.56% (4/72) | 5.33 | 3e-06 | 0.000335 |
GO:0033363 | secretory granule organization | 4.17% (3/72) | 6.67 | 3e-06 | 0.000337 |
GO:0030865 | cortical cytoskeleton organization | 8.33% (6/72) | 3.91 | 3e-06 | 0.000347 |
GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis | 4.17% (3/72) | 6.5 | 5e-06 | 0.000408 |
GO:0060341 | regulation of cellular localization | 12.5% (9/72) | 2.82 | 5e-06 | 0.000412 |
GO:0009396 | folic acid-containing compound biosynthetic process | 4.17% (3/72) | 6.35 | 7e-06 | 0.000524 |
GO:0051246 | regulation of protein metabolic process | 20.83% (15/72) | 1.91 | 8e-06 | 0.000554 |
GO:0004709 | MAP kinase kinase kinase activity | 5.56% (4/72) | 5.02 | 7e-06 | 0.000561 |
GO:0042559 | pteridine-containing compound biosynthetic process | 4.17% (3/72) | 6.28 | 8e-06 | 0.000567 |
GO:0051130 | positive regulation of cellular component organization | 12.5% (9/72) | 2.73 | 8e-06 | 0.00057 |
GO:0032051 | clathrin light chain binding | 2.78% (2/72) | 8.5 | 1e-05 | 0.000602 |
GO:0035159 | regulation of tube length, open tracheal system | 2.78% (2/72) | 8.5 | 1e-05 | 0.000602 |
GO:1990763 | arrestin family protein binding | 2.78% (2/72) | 8.5 | 1e-05 | 0.000602 |
GO:0043228 | non-membrane-bounded organelle | 26.39% (19/72) | 1.58 | 1.1e-05 | 0.000611 |
GO:0043232 | intracellular non-membrane-bounded organelle | 26.39% (19/72) | 1.58 | 1.1e-05 | 0.000611 |
GO:0019222 | regulation of metabolic process | 41.67% (30/72) | 1.12 | 1e-05 | 0.000655 |
GO:0031323 | regulation of cellular metabolic process | 37.5% (27/72) | 1.2 | 1.2e-05 | 0.000662 |
GO:0051128 | regulation of cellular component organization | 20.83% (15/72) | 1.84 | 1.4e-05 | 0.000726 |
GO:0030117 | membrane coat | 5.56% (4/72) | 4.78 | 1.4e-05 | 0.000731 |
GO:0043408 | regulation of MAPK cascade | 8.33% (6/72) | 3.53 | 1.4e-05 | 0.000733 |
GO:0022402 | cell cycle process | 16.67% (12/72) | 2.12 | 1.7e-05 | 0.000863 |
GO:0099080 | supramolecular complex | 13.89% (10/72) | 2.4 | 1.8e-05 | 0.000895 |
GO:0009889 | regulation of biosynthetic process | 31.94% (23/72) | 1.32 | 1.9e-05 | 0.000904 |
GO:0030506 | ankyrin binding | 2.78% (2/72) | 8.08 | 2e-05 | 0.000908 |
GO:0071439 | clathrin complex | 2.78% (2/72) | 8.08 | 2e-05 | 0.000908 |
GO:0043410 | positive regulation of MAPK cascade | 6.94% (5/72) | 3.88 | 2.4e-05 | 0.001057 |
GO:0007010 | cytoskeleton organization | 12.5% (9/72) | 2.54 | 2.4e-05 | 0.001065 |
GO:0030154 | cell differentiation | 18.06% (13/72) | 1.93 | 3.1e-05 | 0.001303 |
GO:0019899 | enzyme binding | 19.44% (14/72) | 1.83 | 3.2e-05 | 0.001312 |
GO:1900125 | regulation of hyaluronan biosynthetic process | 2.78% (2/72) | 7.76 | 3.3e-05 | 0.001334 |
GO:1900126 | negative regulation of hyaluronan biosynthetic process | 2.78% (2/72) | 7.76 | 3.3e-05 | 0.001334 |
GO:0032879 | regulation of localization | 18.06% (13/72) | 1.91 | 3.4e-05 | 0.001337 |
GO:0031974 | membrane-enclosed lumen | 12.5% (9/72) | 2.45 | 3.9e-05 | 0.001406 |
GO:0043233 | organelle lumen | 12.5% (9/72) | 2.45 | 3.9e-05 | 0.001406 |
GO:0070013 | intracellular organelle lumen | 12.5% (9/72) | 2.45 | 3.9e-05 | 0.001406 |
GO:0022607 | cellular component assembly | 20.83% (15/72) | 1.72 | 3.8e-05 | 0.001436 |
GO:0008298 | intracellular mRNA localization | 4.17% (3/72) | 5.54 | 3.8e-05 | 0.001448 |
GO:0140694 | non-membrane-bounded organelle assembly | 8.33% (6/72) | 3.23 | 4.5e-05 | 0.001574 |
GO:0000281 | mitotic cytokinesis | 5.56% (4/72) | 4.36 | 4.6e-05 | 0.001578 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 27.78% (20/72) | 1.37 | 5.1e-05 | 0.00167 |
GO:0035002 | liquid clearance, open tracheal system | 2.78% (2/72) | 7.5 | 5e-05 | 0.001671 |
GO:0042045 | epithelial fluid transport | 2.78% (2/72) | 7.5 | 5e-05 | 0.001671 |
GO:0031032 | actomyosin structure organization | 4.17% (3/72) | 5.38 | 5.2e-05 | 0.001692 |
GO:0051252 | regulation of RNA metabolic process | 26.39% (19/72) | 1.41 | 5.3e-05 | 0.001701 |
GO:0051403 | stress-activated MAPK cascade | 4.17% (3/72) | 5.35 | 5.6e-05 | 0.00177 |
GO:1903047 | mitotic cell cycle process | 11.11% (8/72) | 2.57 | 5.9e-05 | 0.001823 |
GO:0006907 | pinocytosis | 4.17% (3/72) | 5.31 | 6.1e-05 | 0.00185 |
GO:0031152 | aggregation involved in sorocarp development | 4.17% (3/72) | 5.24 | 7e-05 | 0.001859 |
GO:0042558 | pteridine-containing compound metabolic process | 4.17% (3/72) | 5.24 | 7e-05 | 0.001859 |
GO:0110165 | cellular anatomical entity | 81.94% (59/72) | 0.45 | 6.2e-05 | 0.001872 |
GO:0005049 | nuclear export signal receptor activity | 2.78% (2/72) | 7.28 | 7e-05 | 0.001901 |
GO:0035151 | regulation of tube size, open tracheal system | 2.78% (2/72) | 7.28 | 7e-05 | 0.001901 |
GO:0046666 | retinal cell programmed cell death | 2.78% (2/72) | 7.28 | 7e-05 | 0.001901 |
GO:0046667 | compound eye retinal cell programmed cell death | 2.78% (2/72) | 7.28 | 7e-05 | 0.001901 |
GO:0006760 | folic acid-containing compound metabolic process | 4.17% (3/72) | 5.28 | 6.5e-05 | 0.001905 |
GO:0031098 | stress-activated protein kinase signaling cascade | 4.17% (3/72) | 5.28 | 6.5e-05 | 0.001905 |
GO:0010564 | regulation of cell cycle process | 11.11% (8/72) | 2.54 | 6.9e-05 | 0.001989 |
GO:0045451 | pole plasm oskar mRNA localization | 2.78% (2/72) | 7.08 | 9.3e-05 | 0.002403 |
GO:1990498 | mitotic spindle microtubule | 2.78% (2/72) | 7.08 | 9.3e-05 | 0.002403 |
GO:0019901 | protein kinase binding | 9.72% (7/72) | 2.71 | 9.9e-05 | 0.00243 |
GO:0042398 | cellular modified amino acid biosynthetic process | 4.17% (3/72) | 5.08 | 9.8e-05 | 0.002431 |
GO:0010344 | seed oilbody biogenesis | 4.17% (3/72) | 5.08 | 9.8e-05 | 0.002431 |
GO:0005938 | cell cortex | 6.94% (5/72) | 3.46 | 9.6e-05 | 0.002446 |
GO:0005829 | cytosol | 31.94% (23/72) | 1.16 | 0.000106 | 0.002496 |
GO:0005764 | lysosome | 6.94% (5/72) | 3.43 | 0.000105 | 0.002499 |
GO:0031401 | positive regulation of protein modification process | 9.72% (7/72) | 2.7 | 0.000103 | 0.002505 |
GO:0032880 | regulation of protein localization | 9.72% (7/72) | 2.69 | 0.000105 | 0.002528 |
GO:0005575 | cellular_component | 81.94% (59/72) | 0.43 | 0.00011 | 0.002558 |
GO:0030130 | clathrin coat of trans-Golgi network vesicle | 2.78% (2/72) | 6.91 | 0.000119 | 0.002621 |
GO:0030669 | clathrin-coated endocytic vesicle membrane | 2.78% (2/72) | 6.91 | 0.000119 | 0.002621 |
GO:0031326 | regulation of cellular biosynthetic process | 29.17% (21/72) | 1.24 | 0.000118 | 0.002649 |
GO:0097718 | disordered domain specific binding | 4.17% (3/72) | 5.0 | 0.000117 | 0.002656 |
GO:0006403 | RNA localization | 4.17% (3/72) | 5.0 | 0.000117 | 0.002656 |
GO:0000910 | cytokinesis | 6.94% (5/72) | 3.37 | 0.000129 | 0.002762 |
GO:0030030 | cell projection organization | 8.33% (6/72) | 2.96 | 0.000128 | 0.002769 |
GO:0009967 | positive regulation of signal transduction | 12.5% (9/72) | 2.19 | 0.00015 | 0.002952 |
GO:0007316 | pole plasm RNA localization | 2.78% (2/72) | 6.76 | 0.000149 | 0.002955 |
GO:0008103 | oocyte microtubule cytoskeleton polarization | 2.78% (2/72) | 6.76 | 0.000149 | 0.002955 |
GO:0019094 | pole plasm mRNA localization | 2.78% (2/72) | 6.76 | 0.000149 | 0.002955 |
GO:0033227 | dsRNA transport | 2.78% (2/72) | 6.76 | 0.000149 | 0.002955 |
GO:0060811 | intracellular mRNA localization involved in anterior/posterior axis specification | 2.78% (2/72) | 6.76 | 0.000149 | 0.002955 |
GO:0030141 | secretory granule | 5.56% (4/72) | 3.93 | 0.000142 | 0.003014 |
GO:0006807 | nitrogen compound metabolic process | 48.61% (35/72) | 0.8 | 0.000156 | 0.003027 |
GO:0051649 | establishment of localization in cell | 15.28% (11/72) | 1.91 | 0.000146 | 0.003062 |
GO:0099503 | secretory vesicle | 6.94% (5/72) | 3.32 | 0.000148 | 0.003079 |
GO:0006897 | endocytosis | 6.94% (5/72) | 3.29 | 0.000164 | 0.003152 |
GO:0006355 | regulation of DNA-templated transcription | 23.61% (17/72) | 1.39 | 0.000176 | 0.00336 |
GO:0010605 | negative regulation of macromolecule metabolic process | 20.83% (15/72) | 1.52 | 0.000178 | 0.003373 |
GO:2001141 | regulation of RNA biosynthetic process | 23.61% (17/72) | 1.39 | 0.000183 | 0.003374 |
GO:1903506 | regulation of nucleic acid-templated transcription | 23.61% (17/72) | 1.39 | 0.000182 | 0.003381 |
GO:0033572 | transferrin transport | 2.78% (2/72) | 6.63 | 0.000182 | 0.003409 |
GO:0010468 | regulation of gene expression | 29.17% (21/72) | 1.19 | 0.000189 | 0.003446 |
GO:0048513 | animal organ development | 12.5% (9/72) | 2.14 | 0.000195 | 0.003462 |
GO:0045995 | regulation of embryonic development | 5.56% (4/72) | 3.82 | 0.000194 | 0.003465 |
GO:0048522 | positive regulation of cellular process | 30.56% (22/72) | 1.14 | 0.000197 | 0.003468 |
GO:0030665 | clathrin-coated vesicle membrane | 4.17% (3/72) | 4.74 | 0.0002 | 0.003484 |
GO:0043170 | macromolecule metabolic process | 41.67% (30/72) | 0.9 | 0.000193 | 0.003485 |
GO:0090304 | nucleic acid metabolic process | 22.22% (16/72) | 1.43 | 0.00021 | 0.00364 |
GO:0046326 | positive regulation of glucose import | 2.78% (2/72) | 6.5 | 0.000218 | 0.003711 |
GO:0098850 | extrinsic component of synaptic vesicle membrane | 2.78% (2/72) | 6.5 | 0.000218 | 0.003711 |
GO:0043229 | intracellular organelle | 61.11% (44/72) | 0.61 | 0.000227 | 0.003804 |
GO:0043934 | sporulation | 6.94% (5/72) | 3.19 | 0.000226 | 0.003812 |
GO:1902850 | microtubule cytoskeleton organization involved in mitosis | 5.56% (4/72) | 3.73 | 0.000246 | 0.004084 |
GO:0030132 | clathrin coat of coated pit | 2.78% (2/72) | 6.38 | 0.000258 | 0.004107 |
GO:0030315 | T-tubule | 2.78% (2/72) | 6.38 | 0.000258 | 0.004107 |
GO:0030620 | U2 snRNA binding | 2.78% (2/72) | 6.38 | 0.000258 | 0.004107 |
GO:0007254 | JNK cascade | 2.78% (2/72) | 6.38 | 0.000258 | 0.004107 |
GO:0031434 | mitogen-activated protein kinase kinase binding | 2.78% (2/72) | 6.38 | 0.000258 | 0.004107 |
GO:0043226 | organelle | 61.11% (44/72) | 0.61 | 0.000264 | 0.004148 |
GO:0023056 | positive regulation of signaling | 12.5% (9/72) | 2.08 | 0.000267 | 0.004157 |
GO:0032886 | regulation of microtubule-based process | 5.56% (4/72) | 3.69 | 0.00027 | 0.004171 |
GO:0023061 | signal release | 4.17% (3/72) | 4.6 | 0.000264 | 0.004173 |
GO:0005488 | binding | 70.83% (51/72) | 0.5 | 0.000275 | 0.004223 |
GO:0061640 | cytoskeleton-dependent cytokinesis | 5.56% (4/72) | 3.68 | 0.000282 | 0.004298 |
GO:0000323 | lytic vacuole | 6.94% (5/72) | 3.12 | 0.000288 | 0.004349 |
GO:0010647 | positive regulation of cell communication | 12.5% (9/72) | 2.06 | 0.000291 | 0.004374 |
GO:0010828 | positive regulation of glucose transmembrane transport | 2.78% (2/72) | 6.28 | 0.0003 | 0.004472 |
GO:0036289 | peptidyl-serine autophosphorylation | 4.17% (3/72) | 4.52 | 0.000313 | 0.00463 |
GO:0003725 | double-stranded RNA binding | 4.17% (3/72) | 4.5 | 0.000326 | 0.00479 |
GO:0016079 | synaptic vesicle exocytosis | 2.78% (2/72) | 6.18 | 0.000346 | 0.004903 |
GO:0035152 | regulation of tube architecture, open tracheal system | 2.78% (2/72) | 6.18 | 0.000346 | 0.004903 |
GO:0098835 | presynaptic endocytic zone membrane | 2.78% (2/72) | 6.18 | 0.000346 | 0.004903 |
GO:2000370 | positive regulation of clathrin-dependent endocytosis | 2.78% (2/72) | 6.18 | 0.000346 | 0.004903 |
GO:0051276 | chromosome organization | 8.33% (6/72) | 2.69 | 0.000339 | 0.004949 |
GO:0009893 | positive regulation of metabolic process | 23.61% (17/72) | 1.29 | 0.000397 | 0.0053 |
GO:1900078 | positive regulation of cellular response to insulin stimulus | 2.78% (2/72) | 6.08 | 0.000395 | 0.005302 |
GO:0048268 | clathrin coat assembly | 2.78% (2/72) | 6.08 | 0.000395 | 0.005302 |
GO:0050750 | low-density lipoprotein particle receptor binding | 2.78% (2/72) | 6.08 | 0.000395 | 0.005302 |
GO:0060810 | intracellular mRNA localization involved in pattern specification process | 2.78% (2/72) | 6.08 | 0.000395 | 0.005302 |
GO:0070325 | lipoprotein particle receptor binding | 2.78% (2/72) | 6.08 | 0.000395 | 0.005302 |
GO:0033036 | macromolecule localization | 16.67% (12/72) | 1.65 | 0.000377 | 0.005307 |
GO:0050657 | nucleic acid transport | 5.56% (4/72) | 3.54 | 0.000405 | 0.00533 |
GO:0050658 | RNA transport | 5.56% (4/72) | 3.54 | 0.000405 | 0.00533 |
GO:0030662 | coated vesicle membrane | 4.17% (3/72) | 4.42 | 0.000383 | 0.005347 |
GO:0140513 | nuclear protein-containing complex | 13.89% (10/72) | 1.87 | 0.000386 | 0.005362 |
GO:0051236 | establishment of RNA localization | 5.56% (4/72) | 3.53 | 0.000413 | 0.005404 |
GO:0048856 | anatomical structure development | 37.5% (27/72) | 0.91 | 0.000426 | 0.005537 |
GO:0034641 | cellular nitrogen compound metabolic process | 29.17% (21/72) | 1.1 | 0.000451 | 0.005712 |
GO:0051049 | regulation of transport | 13.89% (10/72) | 1.84 | 0.000449 | 0.005731 |
GO:0090110 | COPII-coated vesicle cargo loading | 2.78% (2/72) | 6.0 | 0.000447 | 0.005738 |
GO:0030125 | clathrin vesicle coat | 2.78% (2/72) | 6.0 | 0.000447 | 0.005738 |
GO:0070925 | organelle assembly | 8.33% (6/72) | 2.61 | 0.000465 | 0.005861 |
GO:0032502 | developmental process | 45.83% (33/72) | 0.76 | 0.000469 | 0.005875 |
GO:0032506 | cytokinetic process | 4.17% (3/72) | 4.31 | 0.000478 | 0.00595 |
GO:0033298 | contractile vacuole organization | 2.78% (2/72) | 5.91 | 0.000502 | 0.006213 |
GO:0009892 | negative regulation of metabolic process | 20.83% (15/72) | 1.37 | 0.000534 | 0.006565 |
GO:0030127 | COPII vesicle coat | 2.78% (2/72) | 5.84 | 0.000561 | 0.006731 |
GO:0070971 | endoplasmic reticulum exit site | 2.78% (2/72) | 5.84 | 0.000561 | 0.006731 |
GO:0007260 | tyrosine phosphorylation of STAT protein | 2.78% (2/72) | 5.84 | 0.000561 | 0.006731 |
GO:0070727 | cellular macromolecule localization | 15.28% (11/72) | 1.69 | 0.000565 | 0.006739 |
GO:0140535 | intracellular protein-containing complex | 11.11% (8/72) | 2.1 | 0.000554 | 0.006775 |
GO:0043933 | protein-containing complex organization | 13.89% (10/72) | 1.8 | 0.000573 | 0.006794 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 4.17% (3/72) | 4.21 | 0.000588 | 0.006894 |
GO:0018212 | peptidyl-tyrosine modification | 4.17% (3/72) | 4.21 | 0.000588 | 0.006894 |
GO:0050789 | regulation of biological process | 52.78% (38/72) | 0.65 | 0.000597 | 0.00696 |
GO:0007017 | microtubule-based process | 9.72% (7/72) | 2.28 | 0.000605 | 0.006976 |
GO:0050790 | regulation of catalytic activity | 12.5% (9/72) | 1.92 | 0.000604 | 0.007006 |
GO:0030479 | actin cortical patch | 2.78% (2/72) | 5.76 | 0.000622 | 0.007095 |
GO:0061645 | endocytic patch | 2.78% (2/72) | 5.76 | 0.000622 | 0.007095 |
GO:0140718 | facultative heterochromatin formation | 4.17% (3/72) | 4.16 | 0.000648 | 0.007349 |
GO:0051050 | positive regulation of transport | 8.33% (6/72) | 2.51 | 0.000666 | 0.007511 |
GO:1904580 | regulation of intracellular mRNA localization | 2.78% (2/72) | 5.69 | 0.000687 | 0.007619 |
GO:0046324 | regulation of glucose import | 2.78% (2/72) | 5.69 | 0.000687 | 0.007619 |
GO:0043648 | dicarboxylic acid metabolic process | 5.56% (4/72) | 3.34 | 0.000683 | 0.007664 |
GO:0048518 | positive regulation of biological process | 33.33% (24/72) | 0.95 | 0.000712 | 0.007851 |
GO:0071244 | cellular response to carbon dioxide | 4.17% (3/72) | 4.08 | 0.000757 | 0.008008 |
GO:0005856 | cytoskeleton | 8.33% (6/72) | 2.47 | 0.000762 | 0.008013 |
GO:0032060 | bleb assembly | 2.78% (2/72) | 5.63 | 0.000755 | 0.008022 |
GO:0006895 | Golgi to endosome transport | 2.78% (2/72) | 5.63 | 0.000755 | 0.008022 |
GO:0098684 | photoreceptor ribbon synapse | 2.78% (2/72) | 5.63 | 0.000755 | 0.008022 |
GO:0000124 | SAGA complex | 2.78% (2/72) | 5.63 | 0.000755 | 0.008022 |
GO:1904894 | positive regulation of receptor signaling pathway via STAT | 2.78% (2/72) | 5.63 | 0.000755 | 0.008022 |
GO:1903076 | regulation of protein localization to plasma membrane | 4.17% (3/72) | 4.1 | 0.000735 | 0.00806 |
GO:0007281 | germ cell development | 5.56% (4/72) | 3.3 | 0.000745 | 0.008126 |
GO:0010604 | positive regulation of macromolecule metabolic process | 20.83% (15/72) | 1.32 | 0.000795 | 0.008322 |
GO:0000183 | rDNA heterochromatin formation | 2.78% (2/72) | 5.56 | 0.000826 | 0.008425 |
GO:0071459 | protein localization to chromosome, centromeric region | 2.78% (2/72) | 5.56 | 0.000826 | 0.008425 |
GO:0010827 | regulation of glucose transmembrane transport | 2.78% (2/72) | 5.56 | 0.000826 | 0.008425 |
GO:0035150 | regulation of tube size | 2.78% (2/72) | 5.56 | 0.000826 | 0.008425 |
GO:1990381 | ubiquitin-specific protease binding | 2.78% (2/72) | 5.56 | 0.000826 | 0.008425 |
GO:0046907 | intracellular transport | 12.5% (9/72) | 1.85 | 0.000842 | 0.008552 |
GO:0048519 | negative regulation of biological process | 30.56% (22/72) | 0.99 | 0.000851 | 0.008558 |
GO:0019900 | kinase binding | 9.72% (7/72) | 2.19 | 0.000851 | 0.008595 |
GO:0065003 | protein-containing complex assembly | 12.5% (9/72) | 1.84 | 0.000869 | 0.008692 |
GO:0004712 | protein serine/threonine/tyrosine kinase activity | 4.17% (3/72) | 4.01 | 0.000877 | 0.008735 |
GO:0031034 | myosin filament assembly | 2.78% (2/72) | 5.5 | 0.0009 | 0.008785 |
GO:0007291 | sperm individualization | 2.78% (2/72) | 5.5 | 0.0009 | 0.008785 |
GO:0030118 | clathrin coat | 2.78% (2/72) | 5.5 | 0.0009 | 0.008785 |
GO:0005737 | cytoplasm | 22.22% (16/72) | 1.24 | 0.000888 | 0.008802 |
GO:0050794 | regulation of cellular process | 47.22% (34/72) | 0.69 | 0.000911 | 0.008857 |
GO:0008104 | protein localization | 13.89% (10/72) | 1.7 | 0.000938 | 0.009029 |
GO:0051726 | regulation of cell cycle | 11.11% (8/72) | 1.98 | 0.000934 | 0.009032 |
GO:1904375 | regulation of protein localization to cell periphery | 4.17% (3/72) | 3.97 | 0.000955 | 0.009151 |
GO:0031033 | myosin filament organization | 2.78% (2/72) | 5.44 | 0.000977 | 0.009314 |
GO:0051641 | cellular localization | 16.67% (12/72) | 1.5 | 0.000986 | 0.009363 |
GO:0019904 | protein domain specific binding | 8.33% (6/72) | 2.39 | 0.001001 | 0.009459 |
GO:0031399 | regulation of protein modification process | 11.11% (8/72) | 1.96 | 0.001007 | 0.00947 |
GO:0140142 | nucleocytoplasmic carrier activity | 2.78% (2/72) | 5.38 | 0.001057 | 0.009848 |
GO:0097470 | ribbon synapse | 2.78% (2/72) | 5.38 | 0.001057 | 0.009848 |
GO:0065009 | regulation of molecular function | 15.28% (11/72) | 1.56 | 0.001157 | 0.010735 |
GO:0023051 | regulation of signaling | 19.44% (14/72) | 1.32 | 0.001174 | 0.010843 |
GO:0004713 | protein tyrosine kinase activity | 5.56% (4/72) | 3.11 | 0.001231 | 0.011163 |
GO:0035459 | vesicle cargo loading | 2.78% (2/72) | 5.28 | 0.001226 | 0.011172 |
GO:0009920 | cell plate formation involved in plant-type cell wall biogenesis | 2.78% (2/72) | 5.28 | 0.001226 | 0.011172 |
GO:0150093 | amyloid-beta clearance by transcytosis | 2.78% (2/72) | 5.28 | 0.001226 | 0.011172 |
GO:0010646 | regulation of cell communication | 19.44% (14/72) | 1.31 | 0.001258 | 0.011363 |
GO:0007033 | vacuole organization | 5.56% (4/72) | 3.09 | 0.001285 | 0.011557 |
GO:0032501 | multicellular organismal process | 33.33% (24/72) | 0.89 | 0.001294 | 0.011584 |
GO:1903077 | negative regulation of protein localization to plasma membrane | 2.78% (2/72) | 5.18 | 0.001408 | 0.012492 |
GO:1904376 | negative regulation of protein localization to cell periphery | 2.78% (2/72) | 5.18 | 0.001408 | 0.012492 |
GO:0031248 | protein acetyltransferase complex | 4.17% (3/72) | 3.76 | 0.001442 | 0.012687 |
GO:1902493 | acetyltransferase complex | 4.17% (3/72) | 3.76 | 0.001442 | 0.012687 |
GO:0009653 | anatomical structure morphogenesis | 20.83% (15/72) | 1.23 | 0.001477 | 0.012938 |
GO:0031523 | Myb complex | 2.78% (2/72) | 5.13 | 0.001503 | 0.013053 |
GO:0060236 | regulation of mitotic spindle organization | 2.78% (2/72) | 5.13 | 0.001503 | 0.013053 |
GO:0009887 | animal organ morphogenesis | 5.56% (4/72) | 3.02 | 0.001521 | 0.013156 |
GO:0033043 | regulation of organelle organization | 9.72% (7/72) | 2.03 | 0.001615 | 0.013905 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 12.5% (9/72) | 1.71 | 0.001629 | 0.013912 |
GO:0032386 | regulation of intracellular transport | 5.56% (4/72) | 3.0 | 0.001628 | 0.013959 |
GO:0007052 | mitotic spindle organization | 4.17% (3/72) | 3.69 | 0.001658 | 0.014103 |
GO:0031623 | receptor internalization | 2.78% (2/72) | 5.04 | 0.001703 | 0.014241 |
GO:0045056 | transcytosis | 2.78% (2/72) | 5.04 | 0.001703 | 0.014241 |
GO:0099643 | signal release from synapse | 2.78% (2/72) | 5.04 | 0.001703 | 0.014241 |
GO:0005515 | protein binding | 55.56% (40/72) | 0.55 | 0.001714 | 0.014282 |
GO:1905475 | regulation of protein localization to membrane | 4.17% (3/72) | 3.68 | 0.001696 | 0.014365 |
GO:0070889 | platelet alpha granule organization | 1.39% (1/72) | 9.08 | 0.001842 | 0.01486 |
GO:0061863 | microtubule plus end polymerase | 1.39% (1/72) | 9.08 | 0.001842 | 0.01486 |
GO:0007535 | donor selection | 1.39% (1/72) | 9.08 | 0.001842 | 0.01486 |
GO:0003848 | 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase activity | 1.39% (1/72) | 9.08 | 0.001842 | 0.01486 |
GO:0004156 | dihydropteroate synthase activity | 1.39% (1/72) | 9.08 | 0.001842 | 0.01486 |
GO:0009966 | regulation of signal transduction | 18.06% (13/72) | 1.32 | 0.001809 | 0.014884 |
GO:0098590 | plasma membrane region | 8.33% (6/72) | 2.22 | 0.001853 | 0.014892 |
GO:0090224 | regulation of spindle organization | 2.78% (2/72) | 5.0 | 0.001807 | 0.01493 |
GO:0097242 | amyloid-beta clearance | 2.78% (2/72) | 5.0 | 0.001807 | 0.01493 |
GO:2000369 | regulation of clathrin-dependent endocytosis | 2.78% (2/72) | 4.96 | 0.001914 | 0.015142 |
GO:0070461 | SAGA-type complex | 2.78% (2/72) | 4.96 | 0.001914 | 0.015142 |
GO:0046822 | regulation of nucleocytoplasmic transport | 4.17% (3/72) | 3.63 | 0.001894 | 0.015158 |
GO:0006139 | nucleobase-containing compound metabolic process | 22.22% (16/72) | 1.14 | 0.001907 | 0.015201 |
GO:0000165 | MAPK cascade | 4.17% (3/72) | 3.61 | 0.001935 | 0.015248 |
GO:0046483 | heterocycle metabolic process | 26.39% (19/72) | 1.0 | 0.001995 | 0.015661 |
GO:0070633 | transepithelial transport | 2.78% (2/72) | 4.91 | 0.002024 | 0.015829 |
GO:0010256 | endomembrane system organization | 2.78% (2/72) | 4.88 | 0.002137 | 0.016587 |
GO:0048523 | negative regulation of cellular process | 23.61% (17/72) | 1.08 | 0.002133 | 0.016613 |
GO:0030031 | cell projection assembly | 4.17% (3/72) | 3.56 | 0.002149 | 0.016615 |
GO:0008092 | cytoskeletal protein binding | 8.33% (6/72) | 2.17 | 0.002163 | 0.016662 |
GO:0009987 | cellular process | 69.44% (50/72) | 0.41 | 0.002206 | 0.016923 |
GO:1900076 | regulation of cellular response to insulin stimulus | 2.78% (2/72) | 4.84 | 0.002253 | 0.016971 |
GO:0048488 | synaptic vesicle endocytosis | 2.78% (2/72) | 4.84 | 0.002253 | 0.016971 |
GO:0140238 | presynaptic endocytosis | 2.78% (2/72) | 4.84 | 0.002253 | 0.016971 |
GO:0042307 | positive regulation of protein import into nucleus | 2.78% (2/72) | 4.84 | 0.002253 | 0.016971 |
GO:0022414 | reproductive process | 31.94% (23/72) | 0.86 | 0.002239 | 0.017113 |
GO:0042981 | regulation of apoptotic process | 8.33% (6/72) | 2.15 | 0.002348 | 0.017556 |
GO:0031507 | heterochromatin formation | 4.17% (3/72) | 3.51 | 0.002377 | 0.017581 |
GO:0043085 | positive regulation of catalytic activity | 6.94% (5/72) | 2.44 | 0.002344 | 0.017588 |
GO:0045176 | apical protein localization | 2.78% (2/72) | 4.8 | 0.002372 | 0.017607 |
GO:0043525 | positive regulation of neuron apoptotic process | 2.78% (2/72) | 4.8 | 0.002372 | 0.017607 |
GO:0070828 | heterochromatin organization | 4.17% (3/72) | 3.5 | 0.002425 | 0.017867 |
GO:0046903 | secretion | 5.56% (4/72) | 2.83 | 0.002494 | 0.018247 |
GO:0048260 | positive regulation of receptor-mediated endocytosis | 2.78% (2/72) | 4.76 | 0.002494 | 0.018312 |
GO:0010037 | response to carbon dioxide | 4.17% (3/72) | 3.46 | 0.00262 | 0.018898 |
GO:0031156 | regulation of sorocarp development | 2.78% (2/72) | 4.73 | 0.002619 | 0.018956 |
GO:1904892 | regulation of receptor signaling pathway via STAT | 2.78% (2/72) | 4.73 | 0.002619 | 0.018956 |
GO:0080135 | regulation of cellular response to stress | 8.33% (6/72) | 2.12 | 0.002613 | 0.019048 |
GO:0120036 | plasma membrane bounded cell projection organization | 5.56% (4/72) | 2.8 | 0.002675 | 0.019087 |
GO:0018193 | peptidyl-amino acid modification | 9.72% (7/72) | 1.9 | 0.002669 | 0.01911 |
GO:0009894 | regulation of catabolic process | 9.72% (7/72) | 1.9 | 0.002669 | 0.01911 |
GO:0006970 | response to osmotic stress | 15.28% (11/72) | 1.4 | 0.002703 | 0.01922 |
GO:1905476 | negative regulation of protein localization to membrane | 2.78% (2/72) | 4.69 | 0.002747 | 0.019398 |
GO:0005816 | spindle pole body | 2.78% (2/72) | 4.69 | 0.002747 | 0.019398 |
GO:0048583 | regulation of response to stimulus | 26.39% (19/72) | 0.96 | 0.002769 | 0.019487 |
GO:0009792 | embryo development ending in birth or egg hatching | 5.56% (4/72) | 2.78 | 0.0028 | 0.019636 |
GO:0016874 | ligase activity | 5.56% (4/72) | 2.78 | 0.002832 | 0.019792 |
GO:0005686 | U2 snRNP | 2.78% (2/72) | 4.66 | 0.002877 | 0.020043 |
GO:0016050 | vesicle organization | 5.56% (4/72) | 2.77 | 0.002896 | 0.020105 |
GO:0007155 | cell adhesion | 4.17% (3/72) | 3.4 | 0.002931 | 0.020212 |
GO:0015931 | nucleobase-containing compound transport | 5.56% (4/72) | 2.76 | 0.002929 | 0.020263 |
GO:0031164 | contractile vacuolar membrane | 2.78% (2/72) | 4.63 | 0.003011 | 0.020621 |
GO:0016881 | acid-amino acid ligase activity | 2.78% (2/72) | 4.63 | 0.003011 | 0.020621 |
GO:0045814 | negative regulation of gene expression, epigenetic | 4.17% (3/72) | 3.37 | 0.003095 | 0.021127 |
GO:0048468 | cell development | 8.33% (6/72) | 2.06 | 0.00323 | 0.021973 |
GO:0035295 | tube development | 4.17% (3/72) | 3.33 | 0.00338 | 0.022768 |
GO:0008340 | determination of adult lifespan | 4.17% (3/72) | 3.33 | 0.00338 | 0.022768 |
GO:0051247 | positive regulation of protein metabolic process | 9.72% (7/72) | 1.84 | 0.003372 | 0.022862 |
GO:0000932 | P-body | 4.17% (3/72) | 3.32 | 0.003439 | 0.023012 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 18.06% (13/72) | 1.21 | 0.003433 | 0.023052 |
GO:0044260 | cellular macromolecule metabolic process | 19.44% (14/72) | 1.15 | 0.003566 | 0.02371 |
GO:0032989 | cellular component morphogenesis | 4.17% (3/72) | 3.3 | 0.003558 | 0.023735 |
GO:0140026 | contractile vacuole dissociation from plasma membrane | 1.39% (1/72) | 8.08 | 0.003681 | 0.023924 |
GO:0004821 | histidine-tRNA ligase activity | 1.39% (1/72) | 8.08 | 0.003681 | 0.023924 |
GO:0006427 | histidyl-tRNA aminoacylation | 1.39% (1/72) | 8.08 | 0.003681 | 0.023924 |
GO:0097355 | protein localization to heterochromatin | 1.39% (1/72) | 8.08 | 0.003681 | 0.023924 |
GO:1902682 | protein localization to pericentric heterochromatin | 1.39% (1/72) | 8.08 | 0.003681 | 0.023924 |
GO:0010995 | free ubiquitin chain depolymerization | 1.39% (1/72) | 8.08 | 0.003681 | 0.023924 |
GO:0000904 | cell morphogenesis involved in differentiation | 9.72% (7/72) | 1.82 | 0.003641 | 0.024129 |
GO:0051703 | biological process involved in intraspecies interaction between organisms | 5.56% (4/72) | 2.66 | 0.00375 | 0.0243 |
GO:1990234 | transferase complex | 9.72% (7/72) | 1.81 | 0.003792 | 0.024489 |
GO:0034764 | positive regulation of transmembrane transport | 4.17% (3/72) | 3.27 | 0.003805 | 0.0245 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 15.28% (11/72) | 1.34 | 0.003875 | 0.024636 |
GO:0007349 | cellularization | 2.78% (2/72) | 4.44 | 0.003871 | 0.02469 |
GO:0065007 | biological regulation | 52.78% (38/72) | 0.52 | 0.003852 | 0.024721 |
GO:0033157 | regulation of intracellular protein transport | 4.17% (3/72) | 3.26 | 0.003869 | 0.024752 |
GO:0006259 | DNA metabolic process | 9.72% (7/72) | 1.8 | 0.003947 | 0.025015 |
GO:0005694 | chromosome | 6.94% (5/72) | 2.26 | 0.004004 | 0.025298 |
GO:0006725 | cellular aromatic compound metabolic process | 27.78% (20/72) | 0.88 | 0.004046 | 0.025489 |
GO:0044093 | positive regulation of molecular function | 8.33% (6/72) | 1.99 | 0.004092 | 0.025698 |
GO:0006886 | intracellular protein transport | 8.33% (6/72) | 1.98 | 0.004189 | 0.026227 |
GO:0031981 | nuclear lumen | 4.17% (3/72) | 3.21 | 0.004262 | 0.026601 |
GO:0036477 | somatodendritic compartment | 2.78% (2/72) | 4.33 | 0.004501 | 0.028005 |
GO:0009898 | cytoplasmic side of plasma membrane | 2.78% (2/72) | 4.3 | 0.004665 | 0.028939 |
GO:0050793 | regulation of developmental process | 22.22% (16/72) | 1.01 | 0.004752 | 0.029391 |
GO:0071987 | WD40-repeat domain binding | 2.78% (2/72) | 4.28 | 0.004832 | 0.029704 |
GO:0042306 | regulation of protein import into nucleus | 2.78% (2/72) | 4.28 | 0.004832 | 0.029704 |
GO:0007610 | behavior | 5.56% (4/72) | 2.53 | 0.005136 | 0.031478 |
GO:0031058 | positive regulation of histone modification | 4.17% (3/72) | 3.11 | 0.005195 | 0.031744 |
GO:0031023 | microtubule organizing center organization | 2.78% (2/72) | 4.2 | 0.005349 | 0.032494 |
GO:0051603 | proteolysis involved in protein catabolic process | 8.33% (6/72) | 1.91 | 0.005346 | 0.032569 |
GO:0045055 | regulated exocytosis | 2.78% (2/72) | 4.18 | 0.005527 | 0.032699 |
GO:0070820 | tertiary granule | 1.39% (1/72) | 7.5 | 0.005516 | 0.032727 |
GO:0043494 | CLRC complex | 1.39% (1/72) | 7.5 | 0.005516 | 0.032727 |
GO:0004819 | glutamine-tRNA ligase activity | 1.39% (1/72) | 7.5 | 0.005516 | 0.032727 |
GO:0006425 | glutaminyl-tRNA aminoacylation | 1.39% (1/72) | 7.5 | 0.005516 | 0.032727 |
GO:0051661 | maintenance of centrosome location | 1.39% (1/72) | 7.5 | 0.005516 | 0.032727 |
GO:0004326 | tetrahydrofolylpolyglutamate synthase activity | 1.39% (1/72) | 7.5 | 0.005516 | 0.032727 |
GO:0019100 | male germ-line sex determination | 1.39% (1/72) | 7.5 | 0.005516 | 0.032727 |
GO:0009756 | carbohydrate mediated signaling | 4.17% (3/72) | 3.07 | 0.005584 | 0.032843 |
GO:0010182 | sugar mediated signaling pathway | 4.17% (3/72) | 3.07 | 0.005584 | 0.032843 |
GO:0051179 | localization | 25.0% (18/72) | 0.9 | 0.00564 | 0.033078 |
GO:0022412 | cellular process involved in reproduction in multicellular organism | 8.33% (6/72) | 1.9 | 0.005464 | 0.033092 |
GO:1901216 | positive regulation of neuron death | 2.78% (2/72) | 4.15 | 0.005708 | 0.03338 |
GO:0030054 | cell junction | 19.44% (14/72) | 1.07 | 0.005857 | 0.034154 |
GO:2000026 | regulation of multicellular organismal development | 13.89% (10/72) | 1.34 | 0.005915 | 0.034396 |
GO:0019538 | protein metabolic process | 25.0% (18/72) | 0.89 | 0.006072 | 0.035205 |
GO:0140096 | catalytic activity, acting on a protein | 20.83% (15/72) | 1.01 | 0.006175 | 0.0357 |
GO:0032154 | cleavage furrow | 2.78% (2/72) | 4.08 | 0.006266 | 0.036023 |
GO:0051656 | establishment of organelle localization | 5.56% (4/72) | 2.45 | 0.006265 | 0.036122 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 5.56% (4/72) | 2.44 | 0.006375 | 0.036551 |
GO:1900182 | positive regulation of protein localization to nucleus | 2.78% (2/72) | 4.06 | 0.006457 | 0.036915 |
GO:0048584 | positive regulation of response to stimulus | 15.28% (11/72) | 1.23 | 0.006526 | 0.037204 |
GO:0022008 | neurogenesis | 2.78% (2/72) | 4.04 | 0.006651 | 0.037602 |
GO:0017069 | snRNA binding | 2.78% (2/72) | 4.04 | 0.006651 | 0.037602 |
GO:0046824 | positive regulation of nucleocytoplasmic transport | 2.78% (2/72) | 4.04 | 0.006651 | 0.037602 |
GO:0035770 | ribonucleoprotein granule | 5.56% (4/72) | 2.42 | 0.006714 | 0.037852 |
GO:0045595 | regulation of cell differentiation | 8.33% (6/72) | 1.83 | 0.006826 | 0.038382 |
GO:0140104 | molecular carrier activity | 2.78% (2/72) | 4.0 | 0.007046 | 0.038765 |
GO:0004812 | aminoacyl-tRNA ligase activity | 2.78% (2/72) | 4.0 | 0.007046 | 0.038765 |
GO:0006418 | tRNA aminoacylation for protein translation | 2.78% (2/72) | 4.0 | 0.007046 | 0.038765 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 2.78% (2/72) | 4.0 | 0.007046 | 0.038765 |
GO:0034502 | protein localization to chromosome | 2.78% (2/72) | 4.0 | 0.007046 | 0.038765 |
GO:0045184 | establishment of protein localization | 9.72% (7/72) | 1.65 | 0.00693 | 0.038859 |
GO:0051716 | cellular response to stimulus | 26.39% (19/72) | 0.84 | 0.007 | 0.039034 |
GO:0033554 | cellular response to stress | 19.44% (14/72) | 1.04 | 0.006995 | 0.039114 |
GO:0003862 | 3-isopropylmalate dehydrogenase activity | 1.39% (1/72) | 7.08 | 0.007348 | 0.039157 |
GO:0005962 | mitochondrial isocitrate dehydrogenase complex (NAD+) | 1.39% (1/72) | 7.08 | 0.007348 | 0.039157 |
GO:0045242 | isocitrate dehydrogenase complex (NAD+) | 1.39% (1/72) | 7.08 | 0.007348 | 0.039157 |
GO:0032048 | cardiolipin metabolic process | 1.39% (1/72) | 7.08 | 0.007348 | 0.039157 |
GO:0005642 | annulate lamellae | 1.39% (1/72) | 7.08 | 0.007348 | 0.039157 |
GO:0030623 | U5 snRNA binding | 1.39% (1/72) | 7.08 | 0.007348 | 0.039157 |
GO:0043240 | Fanconi anaemia nuclear complex | 1.39% (1/72) | 7.08 | 0.007348 | 0.039157 |
GO:0071821 | FANCM-MHF complex | 1.39% (1/72) | 7.08 | 0.007348 | 0.039157 |
GO:0042775 | mitochondrial ATP synthesis coupled electron transport | 1.39% (1/72) | 7.08 | 0.007348 | 0.039157 |
GO:0045501 | regulation of sevenless signaling pathway | 1.39% (1/72) | 7.08 | 0.007348 | 0.039157 |
GO:0045874 | positive regulation of sevenless signaling pathway | 1.39% (1/72) | 7.08 | 0.007348 | 0.039157 |
GO:0060718 | chorionic trophoblast cell differentiation | 1.39% (1/72) | 7.08 | 0.007348 | 0.039157 |
GO:0120025 | plasma membrane bounded cell projection | 9.72% (7/72) | 1.63 | 0.007393 | 0.039294 |
GO:0097435 | supramolecular fiber organization | 5.56% (4/72) | 2.38 | 0.007426 | 0.039365 |
GO:0030133 | transport vesicle | 4.17% (3/72) | 2.91 | 0.007501 | 0.039558 |
GO:0051234 | establishment of localization | 22.22% (16/72) | 0.94 | 0.007486 | 0.039583 |
GO:0043065 | positive regulation of apoptotic process | 4.17% (3/72) | 2.9 | 0.007692 | 0.040151 |
GO:0007051 | spindle organization | 4.17% (3/72) | 2.9 | 0.007692 | 0.040151 |
GO:0009574 | preprophase band | 2.78% (2/72) | 3.93 | 0.00766 | 0.040188 |
GO:0010119 | regulation of stomatal movement | 6.94% (5/72) | 2.03 | 0.007655 | 0.040266 |
GO:0042176 | regulation of protein catabolic process | 5.56% (4/72) | 2.36 | 0.0078 | 0.040609 |
GO:0043038 | amino acid activation | 2.78% (2/72) | 3.91 | 0.007869 | 0.04066 |
GO:0043039 | tRNA aminoacylation | 2.78% (2/72) | 3.91 | 0.007869 | 0.04066 |
GO:0048768 | root hair cell tip growth | 2.78% (2/72) | 3.91 | 0.007869 | 0.04066 |
GO:1901564 | organonitrogen compound metabolic process | 34.72% (25/72) | 0.67 | 0.007977 | 0.041116 |
GO:0000776 | kinetochore | 2.78% (2/72) | 3.89 | 0.008081 | 0.041337 |
GO:0045912 | negative regulation of carbohydrate metabolic process | 2.78% (2/72) | 3.89 | 0.008081 | 0.041337 |
GO:1902494 | catalytic complex | 12.5% (9/72) | 1.36 | 0.008041 | 0.041341 |
GO:0000902 | cell morphogenesis | 11.11% (8/72) | 1.46 | 0.00844 | 0.043064 |
GO:0006575 | cellular modified amino acid metabolic process | 4.17% (3/72) | 2.85 | 0.008485 | 0.043188 |
GO:0000919 | cell plate assembly | 2.78% (2/72) | 3.86 | 0.008513 | 0.043221 |
GO:0009846 | pollen germination | 4.17% (3/72) | 2.83 | 0.008795 | 0.044542 |
GO:0043650 | dicarboxylic acid biosynthetic process | 2.78% (2/72) | 3.8 | 0.00918 | 0.045147 |
GO:0004449 | isocitrate dehydrogenase (NAD+) activity | 1.39% (1/72) | 6.76 | 0.009177 | 0.04524 |
GO:0031209 | SCAR complex | 1.39% (1/72) | 6.76 | 0.009177 | 0.04524 |
GO:0030981 | cortical microtubule cytoskeleton | 1.39% (1/72) | 6.76 | 0.009177 | 0.04524 |
GO:0090052 | regulation of pericentric heterochromatin formation | 1.39% (1/72) | 6.76 | 0.009177 | 0.04524 |
GO:0090053 | positive regulation of pericentric heterochromatin formation | 1.39% (1/72) | 6.76 | 0.009177 | 0.04524 |
GO:0051292 | nuclear pore complex assembly | 1.39% (1/72) | 6.76 | 0.009177 | 0.04524 |
GO:0009301 | snRNA transcription | 1.39% (1/72) | 6.76 | 0.009177 | 0.04524 |
GO:0050928 | negative regulation of positive chemotaxis | 1.39% (1/72) | 6.76 | 0.009177 | 0.04524 |
GO:0061123 | negative regulation of positive chemotaxis to cAMP | 1.39% (1/72) | 6.76 | 0.009177 | 0.04524 |
GO:0009865 | pollen tube adhesion | 1.39% (1/72) | 6.76 | 0.009177 | 0.04524 |
GO:0018105 | peptidyl-serine phosphorylation | 4.17% (3/72) | 2.8 | 0.009325 | 0.045752 |
GO:0044238 | primary metabolic process | 45.83% (33/72) | 0.52 | 0.009074 | 0.04584 |
GO:0044085 | cellular component biogenesis | 6.94% (5/72) | 1.96 | 0.009428 | 0.046147 |
GO:0032940 | secretion by cell | 4.17% (3/72) | 2.79 | 0.009543 | 0.046483 |
GO:0050829 | defense response to Gram-negative bacterium | 4.17% (3/72) | 2.79 | 0.009543 | 0.046483 |
GO:0051347 | positive regulation of transferase activity | 4.17% (3/72) | 2.77 | 0.009874 | 0.047756 |
GO:0010623 | programmed cell death involved in cell development | 2.78% (2/72) | 3.74 | 0.009869 | 0.047846 |
GO:0030198 | extracellular matrix organization | 2.78% (2/72) | 3.74 | 0.009869 | 0.047846 |
GO:0030659 | cytoplasmic vesicle membrane | 6.94% (5/72) | 1.94 | 0.009927 | 0.047896 |
GO:0043025 | neuronal cell body | 4.17% (3/72) | 2.76 | 0.009986 | 0.04807 |
GO:0001676 | long-chain fatty acid metabolic process | 2.78% (2/72) | 3.73 | 0.010104 | 0.048296 |
GO:0030276 | clathrin binding | 2.78% (2/72) | 3.73 | 0.010104 | 0.048296 |
GO:0043062 | extracellular structure organization | 2.78% (2/72) | 3.73 | 0.010104 | 0.048296 |
GO:0099120 | socially cooperative development | 4.17% (3/72) | 2.75 | 0.010212 | 0.048699 |
GO:0018209 | peptidyl-serine modification | 4.17% (3/72) | 2.74 | 0.010326 | 0.049129 |